Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kathy Mngadi
Centre for the AIDS Programme of Research in South Africa
Study Chair - Paul Goepfert
University of Alabama at Birmingham
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Polana Canico Health Research and Training Center (cispoc), National Institute of Health (ins) Crs
Maputo, Mozambique
- Aurum Tembisa Crs
Johannesburg, Gauteng, South Africa
- Soweto Hvtn Crs
Johannesburg, Gauteng, South Africa
- Ethekwini Crs
Durban, KwaZulu-Natal, South Africa
- Emavundleni Crs
Cape Town, Western Cape, South Africa
- Seke South Crs
Chitungwiza, Mashonaland East Province, Zimbabwe
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jun 2017
- Primary completion
- 12 Dec 2019
- Completion
- 12 Dec 2019
- Last update posted
- 4 May 2026
- Registered enrollment
- 132
- Registry id
- NCT03284710
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.